STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

TRANSCELERATE BIOPHARMA INC: Form 990, tax year 2025

View the entire original 990 at ProPublica ↗

Organization
TRANSCELERATE BIOPHARMA INC (EIN 46-0886344)
Tax period
2025-01-01 to 2025-12-31
Filed
2026-05-14
IRS object ID
202641349349301574
Schema version
2025v4.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2026-05-14T10:08:51-05:00ReturnTs
Tax Period End2025-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN871353108PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1EISNER ADVISORY GROUP LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1130 NORTH 18TH STREET SUITE 3000AddressLine1Txt
CityPHILADELPHIACityNm
State AbbreviationPAStateAbbreviationCd
ZIP191032757ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2025-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN460886344EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1TRANSCELERATE BIOPHARMA INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlTRANBusinessNameControlTxt
Phone4845391230PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1300 CONSHOHOCKEN STATE ROAD 420AddressLine1Txt
CityWEST CONSHOHOCKENCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19428ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJANICE CHANGPersonNm
Person TitleCEOPersonTitleTxt
Phone4845391230PhoneNum
Signature2026-05-06SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonHELEN M MARTINPreparerPersonNm
PTINP01330899PTIN
Phone2158818800PhoneNum
FieldValueIRS element (for citing)
Tax2025TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJANICE CHANGPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1300 CONSHOHOCKEN STATE ROAD 420AddressLine1Txt
CityWEST CONSHOHOCKENCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19428ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$34,242,546GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501cYes (X)Organization501cInd
Website AddressWWW.TRANSCELERATEBIOPHARMAINC.COMWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2012FormationYr
Legal Domicile StateDELegalDomicileStateCd
Activity Or MissionIMPROVE THE HEALTH OF PEOPLE IN THE WORLD BY ENHANCING THE R&D OF INNOVATIVE THERAPIES.ActivityOrMissionDesc
Voting Members Governing Body21VotingMembersGoverningBodyCnt
Voting Members Independent20VotingMembersIndependentCnt
Total Employee35TotalEmployeeCnt
Total Volunteers28TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$0PYContributionsGrantsAmt
CY Contributions Grants$0CYContributionsGrantsAmt
PY Program Service Revenue$37,402,000PYProgramServiceRevenueAmt
CY Program Service Revenue$33,003,000CYProgramServiceRevenueAmt
PY Investment Income$1,193,799PYInvestmentIncomeAmt
CY Investment Income$1,239,546CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$38,595,799PYTotalRevenueAmt
CY Total Revenue$34,242,546CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$9,759,153PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$11,246,091CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$21,980,786PYOtherExpensesAmt
CY Other Expenses$21,786,213CYOtherExpensesAmt
PY Total Expenses$31,739,939PYTotalExpensesAmt
CY Total Expenses$33,032,304CYTotalExpensesAmt
PY Revenues Less Expenses$6,855,860PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,210,242CYRevenuesLessExpensesAmt
Total Assets BOY$55,325,009TotalAssetsBOYAmt
Total Assets EOY$55,072,425TotalAssetsEOYAmt
Total Liabilities BOY$36,830,722TotalLiabilitiesBOYAmt
Total Liabilities EOY$35,380,185TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$18,494,287NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$19,692,240NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$22,040,051ExpenseAmt
Revenue$33,003,000RevenueAmt
DescIN 2025, TRANSCELERATE DELIVERED PRACTICAL SOLUTIONS TO SIMPLIFY TRIAL DESIGN AND EXECUTION, STRENGTHEN QUALITY, AND REDUCE BURDEN ACROSS THE R&D ECOSYSTEM. THE APPROACH COMBINED RAPID IMPROVEMENTS FOR IMMEDIATE IMPLEMENTATION WITH LONG-TERM SOLUTIONS TO HELP PROMISING THERAPIES REACH PATIENTS MORE QUICKLY AND SAFELY.THE ORGANIZATION LED 12 ACTIVE INITIATIVES IN 2025 AND LAUNCHED MORE THAN 60 TOOLS AND SOLUTIONS ACROSS THREE AREAS OF FOCUS:- TRANSFORMING CONNECTIVITY: REDEFINING HOW RESEARCH AND CARE INTERACT- INFORMATION SHARING AND REUSE: LEVERAGING EXISTING DATA FOR FASTER DEVELOPMENT- INNOVATIVE TRIAL DESIGN: PUTTING PATIENTS AT THE HEART OF CLINICAL TRIALS.HIGHLIGHTS OF 2025 PROGRESS:- DIGITAL DATA FLOW (DDF): SPONSORS CONTINUED TO ADOPT DDF WHILE GROWING INTEREST FROM SOLUTION PROVIDERS SHOWED THAT DIGITAL PROTOCOL INNOVATION IS MOVING FROM EARLY PILOT TO EVERYDAY PRACTICE.- ICH E6(R3) SUPPORT: FIFTEEN PRACTICAL TOOLS GAVE THE INDUSTRY WAYS TO ADAPT TO MUCH-ANTICIPATED NEW GUIDANCE ON GOOD CLINICAL PRACTICE EARNING WIDE MEDIA COVERAGE ALONG THE WAY.- CLINICAL DATA SHARING: USAGE OF TRANSCELERATE'S DATACELERATE PLATFORM MORE THAN DOUBLED, DEMONSTRATING THE GROWING IMPACT OF DATA REUSE TO REDUCE BURDEN AND IMPROVE TRIAL DESIGN.- PATIENT SAFETY REPORTING: A MANUSCRIPT IN A PROMINENT JOURNAL AND DIALOGUE WITH MULTIPLE HEALTH AUTHORITIES MARKED CRUCIAL FIRST STEPS TOWARD MODERNIZING INDIVIDUAL CASE SAFETY REPORTING. - EMBEDDED PRAGMATIC TRIALS: TRANSCELERATE PUBLISHED A NEW RESOURCE GUIDE AND IN COLLABORATION WITH THE FDA RELEASED A PUBLIC SUMMARY OF A JOINT EXERCISE TO IDENTIFY ACTIONABLE OPPORTUNITIES TO SCALE THE USE OF PRAGMATIC ELEMENTS.TRANSCELERATE HEALTH AUTHORITY DIALOGUE EXPANDED ACROSS FOUR CONTINENTS WITH CONTINUED FOCUS ON PRODUCTIVE COLLABORATION. THE ORGANIZATION ALSO PARTNERED WITH A VARIETY OF OUTSIDE ORGANIZATIONS, INCLUDING WITH THE TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT (CSDD) TO PUBLISH A BENCHMARKING STUDY ON PROTOCOL COMPLEXITY.- TRANSCELERATE GLOBAL REACH AND PRESENCE EXPANDED IN 2025. HIGHLIGHTS INCLUDED HOSTING 8 PUBLIC WEBINARS REACHING 7,000+ PROFESSIONALS, COVERAGE IN 50+ PUBLICATIONS, AND PRESENTATIONS AT MORE THAN 20 CONFERENCES ACROSS NORTH AMERICA, EUROPE, ASIA, AND SOUTH AMERICA.THE ORGANIZATION'S WORK IN 2025 WAS AND WILL CONTINUE TO BE ORIENTED AROUND A VISION OF SEAMLESS CONVERGENCE OF RESEARCH AND CARE, SO THAT TRIAL PARTICIPATION BECOMES A NATURAL PART OF HEALTHCARE PROCESSES.Desc
Total Program Service Expenses$22,040,051TotalProgramServiceExpensesAmt
Described In Section501c30DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Subject To Proxy TaxYes (1)SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment0ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document21IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee35EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members21GoverningBodyVotingMembersCnt
Independent Voting Member20IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention Policy0DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1ANTHONY GARGES HEAD OF FINANCE AND ADMINISTRATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4845391230PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1300 CONSHOHOCKEN STATE ROAD STE 420AddressLine1Txt
CityWEST CONSHOHOCKENCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19428ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (38 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
JANICE CHANG
CEO40.00Yes (X)Yes (X)$1,174,019$0$53,270
ELIAV BARR
BOARD MEMBER0.50Yes (X)$0$0$0
KAMRAN ANSARI
BOARD MEMBER0.50Yes (X)$0$0$0
LIONEL BASCLES
BOARD MEMBER0.50Yes (X)$0$0$0
DIETMAR BERGER
BOARD MEMBER (EFF 3/2025)0.50Yes (X)$0$0$0
PHILLIPPA BROWN
BOARD MEMBER (EFF 4/2025)0.50Yes (X)$0$0$0
SERBAN GHIORGHIU
BOARD MEMBER (EFF 8/2025)0.50Yes (X)$0$0$0
RUCHIRA GLASER
BOARD MEMBER0.50Yes (X)$0$0$0
LYKKE HINSCH GYLVIN
BOARD MEMBER0.50Yes (X)$0$0$0
ELIZABETH VAN SANT HOFFMAN
BOARD MEMBER (EFF 4/2025)0.50Yes (X)$0$0$0
NARIMON HONARPOUR
BOARD MEMBER0.50Yes (X)$0$0$0
CHRISTOPH KOENEN
BOARD MEMBER0.50Yes (X)$0$0$0
MARIA KOUTSOPOULOU
BOARD MEMBER0.50Yes (X)$0$0$0
BARI KOWAL
BOARD MEMBER0.50Yes (X)$0$0$0
FABIO LIEVANO
BOARD MEMBER0.50Yes (X)$0$0$0
FIONA DU MONCEAU
BOARD MEMBER (EFF 3/2025)0.50Yes (X)$0$0$0
MARIANNE OLHOLM
BOARD MEMBER (EFF 12/2025)0.50Yes (X)$0$0$0
MICHELLE ROHRER
BOARD MEMBER0.50Yes (X)$0$0$0
MOKASH SHARMA
BOARD MEMBER0.50Yes (X)$0$0$0
TADAAKI TANIGUCHI
BOARD MEMBER0.50Yes (X)$0$0$0
TAKEKI UEHARA
BOARD MEMBER (EFF 12/2025)0.50Yes (X)$0$0$0
CHRIS CORSICO
BOARD MEMBER (THRU 3/2025)0.50Yes (X)$0$0$0
CRISTIAN MASSACESI
BOARD MEMBER (THRU 8/2025)0.50Yes (X)$0$0$0
ROBERT METCALF
BOARD MEMBER (THRU 3/2025)0.50Yes (X)$0$0$0
MERDAD PARSEY
BOARD MEMBER (THRU 3/2025)0.50Yes (X)$0$0$0
TOM SENDEROVITZ
BOARD MEMBER (THRU 10/2025)0.50Yes (X)$0$0$0
BADHRI SRINIVASAN
BOARD MEMBER (THRU 1/2025)0.50Yes (X)$0$0$0
TAKUKO YAMADA-SAWADA
BOARD MEMBER (THRU 12/2025)0.50Yes (X)$0$0$0
IRIS LOEW-FRIEDRICH
BOARD MEMBER (THRU 3/2025)0.50Yes (X)$0$0$0
ALLISON CUFF SHIMOOKA
COO40.00Yes (X)$657,690$0$59,759
JENNIFER SHELLER
TREASURER (EFF 8/2025)0.50Yes (X)$0$0$0
RAJA MANGIPUDY
CORPORATE SECRETARY (EFF 4/2025)0.50Yes (X)$0$0$0
ANDREW LEE
TREASURER (THRU 6/2025)0.50Yes (X)$0$0$0
JENNIFER BURGESS
VP, GLOBAL COMM & ENGAG (THRU 7/2025)40.00$486,057$0$51,172Yes (X)
CARA RINALDI
VP, PORTFOLIO MANAGEMENT40.00$448,212$0$59,095Yes (X)
ANTHONY GARGES
HEAD OF FINANCE & ADMINISTRATION40.00$435,545$0$58,512Yes (X)
JENEEN DONADEO
EXEC. PORTFOLIO DIRECTOR40.00$411,601$0$47,045Yes (X)
ROBERT DICICCIO
VP, PORTFOLIO MANAGEMENT40.00$435,340$0$55,553Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$4,048,464TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$384,406TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K28IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmCountryContractorAddress/ForeignAddress/CountryCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCd
PA CONSULTING GROUP INC
10 BRESSENDEN PLACELONDONUKCONSULTING SERVICES$6,966,076
KILPATRICK TOWNSEND
LEGAL SERVICES$3,025,405601 14TH STREET NW SUITE 900WASHINGTONDC20005
ACCENTURE LLP
CONSULTING & IT SERVICES$2,931,600161 N CLARK STREETCHICAGOIL60601
VYNAMIC LLC
CONSULTING SERVICES$1,606,5321600 ARCH STREETPHILADELPHIAPA19103
ARTEMIS FACTOR LLC
CONSULTING SERVICES$1,392,285314 CARLYLE ROADWEST CHESTERPA19382
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K21CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescMEMBERSHIP DUESDesc
Business541900BusinessCd
Total Revenue Column$33,003,000TotalRevenueColumnAmt
Related Or Exempt Func Income$33,003,000RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$33,003,000TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,239,546TotalRevenueColumnAmt
Exclusion$1,239,546ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$34,242,546TotalRevenueColumnAmt
Related Or Exempt Func Income$33,003,000RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,239,546ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,940,738TotalAmt
Management And General$1,940,738ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$7,729,478TotalAmt
Program Services$4,365,622ProgramServicesAmt
Management And General$3,363,856ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$300,338TotalAmt
Program Services$203,902ProgramServicesAmt
Management And General$96,436ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$812,560TotalAmt
Program Services$420,882ProgramServicesAmt
Management And General$391,678ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$462,977TotalAmt
Program Services$307,105ProgramServicesAmt
Management And General$155,872ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$3,005,795TotalAmt
Program Services$1,739,172ProgramServicesAmt
Management And General$1,266,623ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$26,458TotalAmt
Management And General$26,458ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$14,388,053TotalAmt
Program Services$12,990,192ProgramServicesAmt
Management And General$1,397,861ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$40,337TotalAmt
Program Services$17,360ProgramServicesAmt
Management And General$22,977ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$59,848TotalAmt
Management And General$59,848ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,599,472TotalAmt
Program Services$1,873,710ProgramServicesAmt
Management And General$725,762ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$364,676TotalAmt
Management And General$364,676ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$580,873TotalAmt
Program Services$121,043ProgramServicesAmt
Management And General$459,830ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$359,588TotalAmt
Program Services$1,063ProgramServicesAmt
Management And General$358,525ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$262,011TotalAmt
Management And General$262,011ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtManagement And GeneralManagementAndGeneralAmt
EXCESS COMPENSATION TAX$36,861$36,861
RECRUITING$35,896$35,896
ADMINISTRATIVE FEES$18,454$18,454
BOOKS, SUBSCRIPTIONS, R$6,916$6,916

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$975TotalAmt
Management And General$975ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$33,032,304TotalAmt
Program Services$22,040,051ProgramServicesAmt
Management And General$10,992,253ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$2,528,531BOYAmt
EOY$2,528,020EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$21,990,173BOYAmt
EOY$25,203,908EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$30,577,703BOYAmt
EOY$27,074,905EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$201,619BOYAmt
EOY$238,609EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$26,983BOYAmt
EOY$26,983EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$55,325,009BOYAmt
EOY$55,072,425EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$3,827,722BOYAmt
EOY$3,778,185EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$33,003,000BOYAmt
EOY$31,602,000EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$36,830,722BOYAmt
EOY$35,380,185EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$18,494,287BOYAmt
EOY$19,692,240EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$18,494,287BOYAmt
EOY$19,692,240EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$55,325,009BOYAmt
EOY$55,072,425EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$1,210,242ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$12,289NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS Audited0FSAuditedInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Substantially All Dues Nonded0SubstantiallyAllDuesNondedInd
Only In House LobbyingYes (1)OnlyInHouseLobbyingInd
Agree Carryover Prior Year0AgreeCarryoverPriorYearInd

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Written Employment ContractYes (X)WrittenEmploymentContractInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JANICE CHANG
CEO$810,141$0$363,878$0$0$0$21,000$0$32,270$0$1,227,289$0$0$0
ALLISON CUFF SHIMOOKA
COO$456,067$0$201,623$0$0$0$21,000$0$38,759$0$717,449$0$0$0
JENNIFER BURGESS
VP, GLOBAL COMM & ENGAG (THRU 7/2025$221,441$0$105,579$0$159,037$0$14,155$0$37,017$0$537,229$0$0$0
CARA RINALDI
VP, PORTFOLIO MANAGEMENT$337,322$0$110,890$0$0$0$0$0$59,095$0$507,307$0$0$0
ANTHONY GARGES
HEAD OF FINANCE & ADMINISTRATION$351,179$0$84,366$0$0$0$21,000$0$37,512$0$494,057$0$0$0
ROBERT DICICCIO
VP, PORTFOLIO MANAGEMENT$328,123$0$107,217$0$0$0$2,042$0$53,511$0$490,893$0$0$0
JENEEN DONADEO
EXEC. PORTFOLIO DIRECTOR$317,681$0$93,920$0$0$0$21,000$0$26,045$0$458,646$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 3THE ORGANIZATION'S EXECUTIVE COMPENSATION COMMITTEE, CONSISTING OF INDEPENDENT DIRECTORS, ANNUALLY REVIEWS AND APPROVES THE CEO'S COMPENSATION PACKAGE. THE CEO APPROVES THE COMPENSATION FOR THE CHIEF OPERATING OFFICER, AND ALL OTHER KEY EMPLOYEES.
PART I, LINE 4AVICE PRESIDENT, GLOBAL COMMUNICATIONS & ENGAGEMENT RECEIVED A SEVERANCE THROUGH MARCH 2026 OF SALARY, COBRA AND AN $8,000 REIMBURSEMENT FOR TRANSITION COACHING SERVICES.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 6, TOTAL NUMBER OF VOLUNTEERS:THE TOTAL NUMBER OF VOLUNTEERS OF 21, ENCOMPASSES ALL ACTIVE BOARD MEMBER THROUGHOUT THE CALENDAR YEAR.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE CORPORATION CONSIST OF SUCH FIRMS AND CORPORATIONS THAT ARE APPROVED FOR MEMBERSHIP FROM TIME TO TIME BY THE BOARD OF DIRECTORS OR ITS DESIGNEES IN ACCORDANCE WITH THE POLICIES AND PROCEDURES OF THE CORPORATION. THE CORPORATION HAS THE FOLLOWING CATEGORIES OF MEMBERS: A. TIER I MEMBERS - TO BE ELIGIBLE FOR TIER I MEMBERSHIP, A FIRM OR CORPORATION MUST BE A PHARMACEUTICAL OR BIOTECHNOLOGY COMPANY WITH AN ANNUAL BUDGET FOR RESEARCH AND DEVELOPMENT IN EXCESS OF AN AMOUNT EQUAL TO $3.3 BILLION AS OF JANUARY 1, 2024, WHICH AMOUNT SHALL THEREAFTER BE ADJUSTED FOR INFLATION IN ACCORDANCE WITH THE U.S. CPI INDEX (THE "TIER I THRESHOLD"). THE ADJUSTED TIER I THRESHOLD SHALL BE ANNOUNCED TO THE MEMBERS PERIODICALLY BY THE FINANCE COMMITTEE OR THE BOARD OF DIRECTORS. ELIGIBILITY FOR TIER I MEMBERSHIP IS ESTABLISHED BASED UPON THE AVERAGE OF A COMPANY'S PUBLICALLY AVAILABLE RESEARCH AND DEVELOPMENT EXPENDITURES OVER THE PRECEDING THREE (3) YEAR PERIOD. THE INITIAL TIER I MEMBERS ARE FURTHER DEFINED AS THE "CHARTER MEMBERS." B. TIER II MEMBERS - TO BE ELIGIBLE FOR TIER II MEMBERSHIP, A FIRM OR CORPORATION MUST BE A PHARMACEUTICAL OR BIOTECHNOLOGY COMPANY WITH AN ANNUAL BUDGET FOR RESEARCH AND DEVELOPMENT THAT IS LESS THAN THE TIER I THRESHOLD BUT MORE THAN AN AMOUNT EQUAL TO $134 MILLION AS OF JANUARY 1, 2024, WHICH AMOUNT SHALL THEREAFTER BE ADJUSTED FOR INFLATION IN ACCORDANCE WITH THE U.S. CPI INDEX (THE "TIER II THRESHOLD"). THE ADJUSTED TIER II THRESHOLD SHALL BE ANNOUNCED TO THE MEMBERS PERIODICALLY BY THE FINANCE COMMITTEE OR THE BOARD OF DIRECTORS.. ELIGIBILITY FOR TIER II MEMBERSHIP WILL BE ESTABLISHED BASED UPON THE AVERAGE OF A COMPANY'S PUBLICALLY AVAILABLE RESEARCH AND DEVELOPMENT EXPENDITURES OVER THE PRECEDING THREE (3) YEAR PERIOD. C. ASSOCIATE MEMBERS - TO BE ELIGIBLE FOR ASSOCIATE MEMBERSHIP, A FIRM OR CORPORATION MUST BE A PHARMACEUTICAL OR BIOTECHNOLOGY COMPANY WITH AN ANNUAL BUDGET FOR RESEARCH AND DEVELOPMENT THAT IS LESS THAN THE TIER II THRESHOLD.
FORM 990, PART VI, SECTION A, LINE 7ATHE BOARD OF DIRECTORS SHALL BE COMPRISED OF UP TO TWENTY-FOUR (24) DIRECTORS; PROVIDED THAT: (I) TEN (10) SEATS ARE FILLED BY DIRECTORS WHO ARE REPRESENTATIVES OF THE CHARTER MEMBERS; (II) UP TO SEVEN (7) ADDITIONAL SEATS SHALL BE FILLED BY DIRECTORS WHO ARE REPRESENTATIVES OF THE TIER I MEMBERS WHO ARE NOT CHARTER MEMBERS; (III) UP TO SIX (6) SEATS SHALL BE FILLED BY DIRECTORS WHO ARE REPRESENTATIVES OF THE TIER II MEMBERS; AND (IV) ONE (1) SEAT SHALL BE FILLED BY THE CHIEF EXECUTIVE OFFICER OF THE CORPORATION. THE CORPORATION'S BYLAWS STATE THAT DIRECTORS SHALL BE ELECTED OR APPOINTED, AS APPLICABLE, ANNUALLY AT THE ANNUAL MEETING OF MEMBERS AND SHALL SERVE UNTIL THE FOLLOWING ANNUAL MEETING OF MEMBERS AND UNTIL THEIR SUCCESSORS ARE ELECTED OR APPOINTED, AS APPLICABLE, AND QUALIFIED. EACH CHARTER MEMBER SHALL HAVE THE RIGHT TO APPOINT A REPRESENTATIVE OF THE CHARTER MEMBER TO SERVE AS A CHARTER MEMBER DIRECTOR. TIER I AT-LARGE DIRECTORS SHALL BE ELECTED BY A PLURALITY VOTE OF THE TIER I MEMBERS, WHICH INCLUDE THE CHARTER MEMBERS. TIER II DIRECTORS SHALL BE ELECTED BY A PLURALITY VOTE OF THE TIER II MEMBERS. THE CEO DIRECTOR SHALL SERVE EX-OFFICIO, FOR SO LONG AS HE OR SHE SHALL HOLD THE OFFICE OF CHIEF EXECUTIVE OFFICER. EACH TIER I MEMBER SHALL BE ENTITLED TO THREE (3) VOTES AT EVERY MEETING OF MEMBERS ON MATTERS WHICH TIER I MEMBERS ARE ENTITLED TO VOTE. EACH TIER II MEMBER SHALL BE ENTITLED TO ONE (1) VOTE AT EVERY MEETING OF MEMBERS ON MATTERS WHICH TIER II MEMBERS ARE ENTITLED TO VOTE. ASSOCIATE MEMBERS SHALL BE ENTITLED TO NOTICE OF AND TO ATTEND MEETINGS OF THE MEMBERS BUT SHALL NOT BE ENTITLED TO VOTE AT SUCH MEETINGS. NOTWITHSTANDING THE ABOVE, IN ORDER TO BE ELIGIBLE TO VOTE, A MEMBER MUST BE IN GOOD STANDING AND ITS DUES AND ASSESSMENTS PAID IN FULL.
FORM 990, PART VI, SECTION B, LINE 11BTHE FINANCE COMMITTEE AND MANAGEMENT REVIEW AND APPROVE THE FORM 990. THE FORM IS THEN DISTRIBUTED TO ALL MEMBERS OF THE BOARD FOR THEIR REVIEW BEFORE FILING WITH THE INTERNAL REVENUE SERVICE.
FORM 990, PART VI, SECTION B, LINE 12CEACH DIRECTOR AND OFFICER OF THE CORPORATION IS REQUIRED TO ANNUALLY ACKNOWLEDGE THE CONFLICT OF INTEREST POLICY, AFFIRMING THAT SUCH PERSON HAS RECEIVED, READ AND UNDERSTANDS, AND AGREED TO COMPLY WITH THE CONFLICT OF INTEREST POLICY.
FORM 990, PART VI, SECTION B, LINE 15THE ORGANIZATION'S EXECUTIVE COMPENSATION COMMITTEE, CONSISTING OF INDEPENDENT DIRECTORS, ANNUALLY REVIEWS AND APPROVES THE CEO'S COMPENSATION PACKAGE. THE CEO APPROVES THE COMPENSATION FOR THE CHIEF OPERATING OFFICER, AND ALL OTHER KEY EMPLOYEES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION'S GOVERNING DOCUMENTS, FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER CORPORATE POLICIES ARE AVAILABLE UPON REQUEST.
FORM 990, PART IX, LINE 11GPROJECT MANAGEMENT FEES: PROGRAM SERVICE EXPENSES 10,226,712. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 10,226,712. EXTERNAL CONTRACTOR SUPPORT: PROGRAM SERVICE EXPENSES 2,146,789. MANAGEMENT AND GENERAL EXPENSES 152,626. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,299,415. COMMUNICATIONS FEES: PROGRAM SERVICE EXPENSES 616,691. MANAGEMENT AND GENERAL EXPENSES 1,243,573. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,860,264. PAYROLL EXPENSES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 1,662. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,662.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1BIOCELERATE LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1300 CONSHOHOCKEN STATE ROAD STE 420AddressLine1Txt
CityWEST CONSHOHOCKENCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19428ZIPCd
FieldValueIRS element (for citing)
EIN475492971EIN
Primary ActivitiesTO IMPROVE EFFICIENCIES IN PRECLINICAL RESEARCH.PrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd
Total Income$1,037,224TotalIncomeAmt
End Of Year Assets$1,740,865EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1TRANSCELERATE BIOPHARMA INCBusinessNameLine1Txt